• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《抗癌化疗:实际管理与医疗协调(作者译)》

[Anticancer chemotherapy: practical management and medical coordination (author's transl)].

作者信息

Hoerni B, Durand M, Chauvergne J, Brunet R, Lagarde C

出版信息

Bull Cancer. 1978;65(4):395-400.

PMID:747798
Abstract

The authors have studied the conditions of application of a protocol of palliative chemotherapy in breast cancers for the first 100 patients undergoing this protocol. The overall management of the treatment has been satisfactory. The medical team from the cancer center has directed the treatments; however, their participation, although substantial has been limited. The participation of other doctors, especially general practitioners, has been important and of good quality. The coordination between the various doctors has been almost always satisfactory. The authors stress the positive aspects of this study: the protocol has been respected in the majority of the cases; the duties have been well distributed among the various participating doctors; good medical cooperation leaves only a few minor details which could be improved. These results encourage the continuation of an approach whereby the general practitioner participates fully with the oncologic team in patient management and cancer control.

摘要

作者研究了针对首批100例接受该方案的乳腺癌患者应用姑息化疗方案的情况。治疗的整体管理令人满意。癌症中心的医疗团队指导了治疗;然而,他们的参与尽管很重要,但却很有限。其他医生,尤其是全科医生的参与很重要且质量很高。不同医生之间的协调几乎总是令人满意的。作者强调了这项研究的积极方面:该方案在大多数情况下都得到了遵守;职责在各个参与医生之间得到了很好的分配;良好的医疗合作只留下了一些可以改进的小细节。这些结果鼓励继续采用一种方法,即全科医生与肿瘤学团队充分合作进行患者管理和癌症控制。

相似文献

1
[Anticancer chemotherapy: practical management and medical coordination (author's transl)].《抗癌化疗:实际管理与医疗协调(作者译)》
Bull Cancer. 1978;65(4):395-400.
2
[Chemotherapy in advanced breast cancer: experience in 100 cases (author's transl)].
Med Clin (Barc). 1982 Mar 16;78(6):211-7.
3
Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
Eur J Cancer (1965). 1980;Suppl 1:125-9.
4
[The hormone and chemotherapy in female metastatic breast cancer (author's transl)].女性转移性乳腺癌中的激素与化疗(作者译)
Schweiz Rundsch Med Prax. 1974 Jan 29;63(4):109-14.
5
[Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)].
Bull Cancer. 1981;68(5):442-8.
6
[Long-term survival after treatment of breast cancer thoracic metastases through the association, right from the beginning, of hormonotherapy and non hormonal antineoplastic chemotherapy (author's transl)].乳腺癌胸壁转移的治疗从一开始就联合激素疗法与非激素抗肿瘤化疗后的长期生存(作者译)
Acta Tuberc Pneumol Belg. 1971 Sep-Dec;62(5):473-77.
7
[Endocrinal and chemotherapy of the metastasising mastocarcinoma (author's transl)].转移性乳癌的内分泌与化学疗法(作者译)
Rontgenblatter. 1978 Jul;31(7):429-34.
8
[Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].[细胞抑制疗法治疗转移性乳腺癌的鼓舞人心的结果(作者译)]
Wien Klin Wochenschr. 1981 Mar 20;93(6):205-7.
9
[Results of various treatments on the malignant pleural effusion of breast cancer (author's transl)].[乳腺癌恶性胸腔积液的各种治疗结果(作者译)]
Rinsho Hoshasen. 1979;24(10):1041-50.
10
[Cytostatic therapy of metastatic breast cancer].
Minerva Chir. 1980;35(15-16):1195-225.